Is Fusion Antibodies PLC stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Fusion Antibodies PLC 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was GBP66.50, you would have made a loss of GBP-62.20 per share or -93.53%
Yes, the average daily trading liquidity for Fusion Antibodies PLC is GBP1.05 million. You should therefore be able to get in and out of your positions relatively fast.
Fusion Antibodies PLC has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Fusion Antibodies PLC to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.